| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
20,983 |
19,782 |
$1.50M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
11,165 |
10,566 |
$1.15M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,325 |
3,324 |
$309K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,533 |
3,036 |
$308K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,616 |
2,616 |
$240K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
10,512 |
10,449 |
$189K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
4,127 |
4,120 |
$151K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,472 |
1,472 |
$149K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,416 |
2,392 |
$101K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,015 |
1,983 |
$79K |
| 94010 |
|
2,559 |
2,559 |
$71K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
6,947 |
6,367 |
$59K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,519 |
3,496 |
$50K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,754 |
1,736 |
$50K |
| 94060 |
|
967 |
965 |
$39K |
| E0570 |
Nebulizer, with compressor |
204 |
204 |
$18K |
| A7010 |
Corrugated tubing, disposable, used with large volume nebulizer, 100 feet |
591 |
591 |
$10K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
358 |
346 |
$7K |
| 96127 |
|
1,045 |
974 |
$5K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
322 |
297 |
$4K |
| 87807 |
|
291 |
289 |
$3K |
| 90480 |
|
60 |
60 |
$2K |
| A7007 |
Large volume nebulizer, disposable, unfilled, used with aerosol compressor |
612 |
608 |
$2K |
| 0072A |
|
52 |
52 |
$2K |
| 96161 |
|
404 |
402 |
$2K |
| 0071A |
|
53 |
53 |
$2K |
| 0001A |
|
91 |
89 |
$2K |
| 0002A |
|
75 |
75 |
$2K |
| 0124A |
|
25 |
25 |
$1K |
| 90674 |
|
1,060 |
1,060 |
$860.06 |
| A7016 |
Dome and mouthpiece, used with small volume ultrasonic nebulizer |
101 |
101 |
$730.76 |
| A7015 |
Aerosol mask, used with dme nebulizer |
508 |
508 |
$714.58 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
41 |
36 |
$629.35 |
| 90661 |
|
276 |
276 |
$241.52 |
| 90686 |
|
1,974 |
1,971 |
$94.42 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
15 |
13 |
$14.50 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
62 |
56 |
$14.10 |
| J7614 |
Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg |
12 |
12 |
$1.62 |
| 96160 |
|
5,033 |
5,031 |
$1.25 |
| 90620 |
|
26 |
26 |
$0.01 |
| 91300 |
|
193 |
182 |
$0.00 |
| 90633 |
|
92 |
92 |
$0.00 |
| 90671 |
|
210 |
210 |
$0.00 |
| 90670 |
|
793 |
793 |
$0.00 |
| 91312 |
|
38 |
38 |
$0.00 |
| 90734 |
|
43 |
43 |
$0.00 |
| 90715 |
|
39 |
39 |
$0.00 |
| 90707 |
|
12 |
12 |
$0.00 |
| 90680 |
|
411 |
411 |
$0.00 |
| 90698 |
|
381 |
381 |
$0.00 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
968 |
955 |
$0.00 |
| 90651 |
|
54 |
54 |
$0.00 |
| 90744 |
|
40 |
40 |
$0.00 |
| 90697 |
|
24 |
24 |
$0.00 |
| 91307 |
|
130 |
122 |
$0.00 |
| 90716 |
|
12 |
12 |
$0.00 |